Atlas Trials

Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Clinical Study

Clinical trial NCT05373446 · UNKNOWN

Trial details

NCT number
NCT05373446
Sponsor
Jiangsu Simcere Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2022-05-20
Primary completion
2022-10-31
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.